CMS to Provide Financial Incentive in Program to Boost EHR Use


Author: Neil Versel
The Centers for Medicare and Medicaid Services (CMS) announced Tuesday that the agency will provide financial incentives for as many as 1,200 small and medium-size primary care practices to adopt electronic health records (EHRs) over a five-year period. Federal officials say the new demonstration program could improve the quality of care for as many as 3.6 million patients — and perhaps more if government efforts to encourage similar initiatives by private payers are successful.

“This project will appropriately align incentives to reward doctors in small physician practices who use certified EHRs as tools to deliver higher quality care,” acting CMS administrator Kerry Weems said during a teleconference from Good Samaritan Hospital in Cincinnati. “This reward structure will bring the benefits of electronic health records to Americans at their most frequent point of contact with health care, their family doctor.”

CMS will honor the ambulatory certification stamp of the private Certification Commission for Healthcare Information Technology (CCHIT).

Health and Human Services (HHS) Secretary Mike Leavitt had been scheduled to make the announcement, but stayed back in Washington to lobby Congress about State Children's Health Insurance Program reauthorization legislation. In a statement released by HHS, Leavitt said, “We are looking for 1,200 physician practice pioneers who will help us move health care toward a system that delivers better quality at lower cost for more Americans.”

CMS is still working on particulars for bonus payments, though Weems said that a detailed benchmark and incentive plan will be ready when recruitment of participating practices begins in late winter or early spring. He made it clear that quality will be the primary consideration, however. “We’re not going to be in the business of paying for acquisition of software,” Weems said.

“We believe that encouraging higher quality care through the use of EHRs benefits every health care stakeholder,” Weems said. “That is why we are asking private insurers to help accelerate certified EHR adoption by offering incentives similar to those in this demonstration.”

While no private payers have officially adopted the program, Weems was joined in Cincinnati by Allan Korn, chief medical officer of the Blue Cross and Blue Shield Association. “This new Medicare incentive pilot to be implemented by the Centers for Medicare and Medicaid Services (CMS) is an important step in recognizing and rewarding providers for delivering quality, coordinated care supported by the adoption and use of an EHR,” Korn said.

Korn touted Blues plans’ support of the Patient-Centered Medical Home model and associated demonstration, involving internal medicine, family, pediatric, and OB/GYN practices in up to 27 states. “We would like to reorganize the primary care physician’s office as a central point for Americans to organize and coordinate their health care,” Korn said. “EHRs are a key to success of those efforts.”

Private payers are free to increase the pool of money available to medical providers, but CMS is constrained by federal rules that require demonstration programs to be budget-neutral. This announcement comes one day after the Medical Group Management Association (MGMA) released a survey showing that physician practices are concerned about the administrative requirements in existing CMS quality-reporting initiatives. (See story.)

Weems said he had not seen the MGMA report, but said, “Our objective would be to have a CCHIT reporting tool available by the third or fourth year of the program.” He said that the CMS program would have enough incentives in the early years to assure that practices would stick around that long.

Want to read more expert articles like this? Click here to subscribe to Digital HealthCare & Productivity.

 

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.